Shares of International Biotechnology Trust plc (LON:IBT – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 657.34 ($8.30) and traded as high as GBX 658.04 ($8.31). International Biotechnology Trust shares last traded at GBX 654 ($8.26), with a volume of 18,381 shares traded.
International Biotechnology Trust Price Performance
The company has a market cap of £255.71 million, a price-to-earnings ratio of 622.86 and a beta of 0.24. The company has a current ratio of 0.27, a quick ratio of 0.32 and a debt-to-equity ratio of 8.19. The company has a fifty day moving average price of GBX 640.23 and a two-hundred day moving average price of GBX 657.34.
International Biotechnology Trust Increases Dividend
The business also recently announced a dividend, which was paid on Friday, August 25th. Stockholders of record on Thursday, July 27th were issued a GBX 14.20 ($0.18) dividend. The ex-dividend date was Thursday, July 27th. This is a boost from International Biotechnology Trust’s previous dividend of $14.00. This represents a dividend yield of 2.15%. International Biotechnology Trust’s dividend payout ratio is presently 2,666.67%.
Insider Activity at International Biotechnology Trust
About International Biotechnology Trust
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.
- Five stocks we like better than International Biotechnology Trust
- How to Invest in E-Commerce: A Guide
- 5 Ways to Play Retail that will Profit in 2023
- What Are Growth Stocks and Investing in Them
- This Is Why It’s Not Too Late For You To Buy Meta Stock
- What Does a Stock Split Mean?
- Why Analysts Say GE’s Healthcare Spinoff Has $20 Upside
Receive News & Ratings for International Biotechnology Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology Trust and related companies with MarketBeat.com's FREE daily email newsletter.